 AstraZeneca PLC LSE:AZN looks set to launch the worlds first rescue medication for asthma sufferers that also reduces the underlying inflammation associated with exacerbations of the condition. A specialist panel of the US Food Drug Administration voted 16 to one that PT027 had a beneficial impact on adults. 